Suchergebnisse - "Foer, Dinah"

PubPharm (45)

21

PASCLex : A comprehensive post-acute sequelae of COVID-19 (PASC) symptom lexicon derived from electronic health record clinical notes

enthalten in: Journal of biomedical informatics | 2022

von Wang, L. | Foer, D. | MacPhaul, E. | +3

22

Evaluation of Allergic Diseases in Transgender and Gender-Diverse Patients : A Case Study of Asthma

enthalten in: The journal of allergy and clinical immunology. In practice | 2022

von Arroyo, A. | Sanchez, D. | Camargo, C. | +2

23

Identifying Individual Medications Affecting Pulmonary Outcomes When Multiple Medications are Present

enthalten in: Clinical epidemiology | 2022

von Li, Y. | Dai, R. | Gwon, Y. | +11

24

Improving Allergy Documentation : A Retrospective Electronic Health Record System-Wide Patient Safety Initiative

enthalten in: Journal of patient safety | 2022

von Li, L. | Foer, D. | Hallisey, R. | +10

25

User-centered design of a scalable, electronic health record-integrated remote symptom monitoring intervention for patients with asthma and providers in primary care

enthalten in: Journal of the American Medical Informatics Association : JAMIA | 2021

von Rudin, R. | Perez, S. | Rodriguez, J. | +6

26

Comment on Albogami et al. Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344-1352

enthalten in: Diabetes care | 2021

von Foer, D. | Cahill, K.

CommentOn: Diabetes Care. 2021 Apr 19;:. - PMID 33875487

27

Development of a Post-Acute Sequelae of COVID-19 (PASC) Symptom Lexicon Using Electronic Health Record Clinical Notes

enthalten in: bioRxiv.org | 2021

von Wang, L. | Foer, D. | MacPhaul, E. | +3

28

COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms

enthalten in: The journal of allergy and clinical immunology. In practice | 2021

von Giannetti, M. | Weller, E. | Alvarez-Twose, I. | +13

29

Asthma Exacerbations in Patients with Type 2 Diabetes and Asthma on Glucagon-like Peptide-1 Receptor Agonists

enthalten in: American journal of respiratory and critical care medicine | 2021

von Foer, D. | Beeler, P. | Cui, J. | +3

CommentIn: Am J Respir Crit Care Med. 2021 Apr 1;203(7):788-789. - PMID 33211980

30

Reply to Watchorn et al. : Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes

enthalten in: American journal of respiratory and critical care medicine | 2021

von Foer, D. | Beeler, P. | Cui, J. | +3

CommentOn: Am J Respir Crit Care Med. 2021 Apr 1;203(7):831-840. - PMID 33052715